When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CELG - FDA OKs Revlimid combo for certain lymphomas
Celgene Corporation
The FDA approves Celgene's (CELG-0.2%) REVLIMID (lenalidomide), combined with a rituximab product (a therapy called R2), for previously treated adult patients with follicular lymphoma or marginal zone lymphoma.
More news on: Celgene Corporation, Bristol-Myers Squibb Company, Healthcare stocks news,